Search results
Amazon, AMD, and Super Micro Sing the Same Sad Song, and 5 Other Things to Know Before Markets Open.
Barrons.com· 3 days agoTesla takes action amid slowing growth at fast-charging stations, Walmart unveils premium...
First trial over Zantac cancer claims set to begin in Chicago
Reuters via Yahoo News· 4 days ago(Reuters) -The first trial over claims that blockbuster heartburn drug Zantac, once sold by GSK and...
Johnson & Johnson proposes $6.5B settlement to resolve talc cancer claims
NJBIZ· 3 days agoJohnson & Johnson hopes to move forward with a $6.48 billion settlement of more than 50,000 lawsuits...
Why a legal fight against the manufacturers of Ozempic, Mounjaro, and other diabetes and weight-loss...
Philly.com· 3 days agoThe patients live all over the country, but the lawsuits that play out in a Philadelphia courtroom...
Coming to a CVS Near You: A Store Brand Monoclonal Antibody
The Wall Street Journal· 6 days agoMany such drugs have been coming off patent in recent years, representing a massive opportunity for...
US challenges 'bogus' patents on Ozempic and other drugs in effort to spur competition
Quartz· 4 days agoThe Federal Trade Commission on Tuesday sent warning letters to 10 drugmakers, taking issue with patents on popular drugs for weight loss, diabetes, asthma and other reparatory ...
Judge rejects J&J, BMS challenges to Medicare drug pricing program
NJBIZ· 3 days agoA federal judge in New Jersey tossed lawsuits from Johnson & Johnson and Bristol Myers Squibb...
One dose of Novo Nordisk's Wegovy back in supply, FDA website shows
Reuters via Yahoo News· 5 days agoIncreasing demand for a type of highly effective diabetes and weight-loss treatment known as GLP-1...
5 Top Stocks to Buy in May
Motley Fool via Yahoo Finance· 4 days agoConsidering the caliber of the new products and indications, I think this target is attainable. Pfizer has also used the huge amount of cash it made from...
Why Weight-Loss Drugs Wegovy, Zepbound Are in Short Supply
Bloomberg· 2 days agoHave a confidential tip for our reporters? Shortages have left patients already on the medications...